BUSINESS OVERVIEW

BioGenex is at the forefront of the emerging discipline of molecular pathology, the study and diagnosis of disease through the examination of molecules within organs, tissues or bodily fluids. The company designs, develops and commercializes systems for Tumor diagnosis, prognosis, precision medicine and life science research. BioGenex’s industry-leading next-generation cytogenetic FISH workflow solution and miRNA system for characterization of Cancer of Unknown Primary (CUP) and undifferentiated tumors are revolutionizing pathology. Proprietary fully-automated molecular pathology workstations from BioGenex are the most advanced systems available globally.